Engineering Spatial-Organized Cardiac Organoids for Developmental Toxicity Testing

Zhen Ma (Inventor), Tackla Winston (Inventor)

Research output: Patent


A developmental toxicity screening assay using spatially organized cardiac organoids with contracting cardiomyocytes in the center surrounded by stromal cells distributed along the pattern perimeter engineered from human induced pluripotent stem cells (hiPSCs). Cardiac organoids generated from 600 μm-diameter circles were used as a developmental toxicity screening assay for the quantification of the embryotoxic potential of nine pharmaceutical compounds. The cardiac organoids were demonstrated as having a potential use as an in vitro platform for studying organoid structure-function relationships, developmental processes, and drug-induced cardiac developmental toxicity.
Original languageEnglish (US)
Priority date6/11/21
Filing date6/10/22
StatePublished - Dec 15 2022


Dive into the research topics of 'Engineering Spatial-Organized Cardiac Organoids for Developmental Toxicity Testing'. Together they form a unique fingerprint.

Cite this